Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Nouv Presse Med ; 11(22): 1738-40, 1982 May 13.
Artigo em Francês | MEDLINE | ID: mdl-6124947

RESUMO

The action of bromazepam was assessed in 30 patients whose dominant symptom was anxiety in clinical presentations of neurosis, depression, drug-addiction or alcoholism, senile dementia or oligophrenia. The doses administered ranged from 6 to 12 mg/day and in some cases from 18 to 36 mg/day. Distinct improvement was noted in 20 patients, the effects of the drug on anxiety being manifested within 2 to 3 days. The somatic symptoms of anxiety and sleep disturbances were also improved. However, depressive and psychotic symptoms remained unchanged and it was necessary to combine diazepam with other drugs. Side-effects consisted of daytime somnolence in 2 cases and feeling of dizziness in 3 cases.


Assuntos
Ansiolíticos/uso terapêutico , Transtornos de Ansiedade/tratamento farmacológico , Bromazepam/uso terapêutico , Adulto , Idoso , Transtornos de Ansiedade/psicologia , Bromazepam/efeitos adversos , Avaliação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...